William H. Milmoe - 15 Apr 2026 Form 4/A - Amendment Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Reporting relationship: Director
Issuer ticker: INBP
Reported as of: 15 Apr 2026
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 17 Apr 2026, 14:17:24 UTC
Original report date: 17 Apr 2026
Prior SEC filing: 25 Mar 2026
Next SEC filing: 25 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ William Milmoe

Key filing fact

William H. Milmoe filed Form 4/A - Amendment for INTEGRATED BIOPHARMA INC (INBP) on 17 Apr 2026.

Key facts

This page summarizes William H. Milmoe's Form 4/A - Amendment filing for INTEGRATED BIOPHARMA INC (INBP).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 17 Apr 2026, 14:17.

Change

Previous filing in this sequence was filed on 25 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0001443194 Primary reporting owner

Milmoe William H.

Relationship: Director
Address: 109 SE 5TH AVENUE, SECOND FLOOR, DELRAY BEACH
Signature: /s/ William Milmoe
Signature date: 17 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INBP transaction

Common Stock

Gift

Transaction value
Shares: -8,966,547
Change %: -79%
Price: $0.000000^*
Shares after: 2,374,084
Date: 15 Apr 2026
Ownership: Trustee or Officer
Footnotes: F1, F2

INBP transaction

Common Stock

Gift

Transaction value
Shares: -2,235,417
Change %: -94%
Price: $0.000000^*
Shares after: 138,667
Date: 15 Apr 2026
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents 8,966,547 shares of Common Stock transferred from CD Financial, LLC, a Florida limited liability company, to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

Footnote F2

Includes 2,235,417 shares of Common Stock owned by the Carl DeSantis Revocable Trust and 138,667 owned by the Reporting Person directly.

Footnote F3

Represents 2,235,417 shares of Common Stock transferred from the Carl DeSantis Revocable Trust to CDDS 2.0, LLC, a Florida limited liability company controlled by Damon DeSantis.

SEC remarks

An incorrect Date of Earliest Transaction date of 03/24/2026 was entered on the original Form 4 in error, the correct date is 04/15/2026.